Abstract
In this multicenter double-blind pilot randomized trial, patient-directed antibiotic duration after symptom resolution demonstrated similar sustained clinical resolution and adverse events compared to fixed-duration treatment among women with pyelonephritis. These findings support the feasibility of this strategy and justify a larger, adequately powered randomized trial to evaluate efficacy and safety. Pyelonephritis; patient-directed antibiotic duration
Funding Information
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (R21AI175751-01)

This publication has 13 references indexed in Scilit: